Featured content
Pharma Horizons: Process Analytical Technology (PAT)
The definitive guide to transitioning from manual, offline batch testing to automated, continuous biomanufacturing.
ArticleClosing the last mile: the key to fully unlocking healthcare value in Europe
Giancarlo Benelli reflects on why Europe must capitalise on its strong innovative drug discovery infrastructure by shoring up the last mile and attracting clinical trials back to Europe’s healthcare systems.
WebinarEnhancing downstream processing for biologic therapies
During this webinar industry experts will share practical insight and considerations for modernising pharmaceutical downstream workflows.
ReportPharma Horizons: Cell and Gene Therapy
Cell and gene therapies are transforming modern medicine, offering new hope for patients with complex and previously untreatable diseases. As innovation advances, the industry must overcome challenges in manufacturing, regulation and scalability to unlock the full potential of these groundbreaking therapies.
News
NewsVertex acquires Crinetics in $10bn endocrinology deal
Acquisition set to bolster Vertex’s rare disease portfolio with addition of two potentially best-in-class endocrine assets.
NewsStudy illustrates alternative to cold chain storage for mRNA vaccines
Research advances dry mRNA vaccine microneedle patch design, potentially improving storage and distribution of these types of vaccines.
NewsAbbVie’s epcoritamab combination approved as first bispecific therapy for follicular lymphoma in EU
European Commission’s approval brings a chemotherapy-free option to patients and develops AbbVie’s oncology and antibody portfolio.
NewsEDQM opens consultation on new revised draft Ph. Eur. monographs
CEP holders are invited to submit feedback on draft monographs for fifteen substances.
From our partners
Pharma Horizons: Process Analytical Technology (PAT)
The definitive guide to transitioning from manual, offline batch testing to automated, continuous biomanufacturing.
Improving patient-centricity with advanced polymer excipients
Optimal excipient choice can enhance both the therapeutic impact and patient-centricity of oral and parenteral formulations.
What Annex 22 spells for AI in GMP manufacturing
Europe’s first dedicated framework for artificial intelligence in GMP manufacturing is close to finalisation and it is more demanding and more consequential than many manufacturers may currently appreciate.
Opinion and interviews
Real-time Raman spectroscopy closes bioprocess control measurement gap
Manual sampling cycles leave bioreactor control decisions hours behind culture dynamics. Process Raman spectroscopy offers continuous, real-time measurement of critical parameters, enabling true closed-loop control in perfusion and continuous bioprocessing applications where measurement lag directly impacts yield and product quality.
More opinion and interviews
- Previous
- Next
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Upcoming Webinars
Webinar
Enhancing downstream processing for biologic therapies
During this webinar industry experts will share practical insight and considerations for modernising pharmaceutical downstream workflows.
Webinar
Implementing reporter assay-based MAT for rapid pyrogen detection
Join this webinar to discover how reporter assay-based MAT can help laboratories accelerate pyrogen testing, simplify workflows and support the transition to animal-free testing while maintaining confidence in results.
Enhancing downstream processing for biologic therapies
Implementing reporter assay-based MAT for rapid pyrogen detection
On-demand Webinars
- Previous
- Next
